Cramer: Biogen Idec's Profit Pipeline

Mad Money's Cramer, takes a look at Biogen Idec's medical breakthrough drugs and its near-term catalysts for growth this year.

CNBC | January 26, 2012

Tags:. .biogen. .catalysts. .breakthrough. .pipeline. .cramer